1] Department of Radiology, Haukeland University Hospital, Jonas Liesvei 65, Postbox 7800, 5021 Bergen, Norway [2] Section for Radiology, Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, 5020 Bergen, Norway.
1] Centre for Cancer Biomarkers, The Gade Institute, Department of Clinical Medicine, University of Bergen, 5020 Bergen, Norway [2] Department of Pathology, Haukeland University Hospital, 5021 Bergen, Norway.
Br J Cancer. 2014 Jan 7;110(1):107-14. doi: 10.1038/bjc.2013.694. Epub 2013 Oct 31.
We aimed to study the angiogenic profile based on histomorphological markers in endometrial carcinomas in relation to imaging parameters obtained from preoperative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI) and to explore the potential value of these markers to identify patients with poor outcome.
In fifty-four surgically staged endometrial carcinoma patients, immunohistochemical staining with factor VIII and Ki67 allowed assessment of microvessel density (MVD) and microvascular proliferation reflecting tumour angiogenesis. In the same patients, preoperative pelvic DCE-MRI and DWI allowed the calculation of parameters describing tumour microvasculature and microstructure in vivo.
Microvascular proliferation was negatively correlated to tumour blood flow (Fb) (r=-0.36, P=0.008), capillary permeability surface area product (PS) (r=-0.39, P=0.004) and transfer from the blood to extravascular extracellular space (EES) (Ktrans) (r=-0.40, P=0.003), and was positively correlated to tumour volume (r=0.34; P=0.004). High-tumour microvascular proliferation, low Fb and low Ktrans were all significantly associated with reduced progression/recurrence-free survival (P<0.05).
Disorganised angiogenesis with coexisting microvascular proliferation and low tumour blood flow is a poor prognostic factor supporting that hypoxia is associated with progression and metastatic spread in endometrial carcinomas.
我们旨在研究子宫内膜癌中基于组织形态学标志物的血管生成特征与术前动态对比增强磁共振成像(DCE-MRI)和弥散加权成像(DWI)获得的成像参数之间的关系,并探讨这些标志物识别预后不良患者的潜在价值。
在 54 例接受手术分期的子宫内膜癌患者中,使用 VIII 因子和 Ki67 的免疫组织化学染色可评估微血管密度(MVD)和微血管增殖,反映肿瘤血管生成。在同一患者中,术前盆腔 DCE-MRI 和 DWI 允许计算描述肿瘤微血管和微结构的参数。
微血管增殖与肿瘤血流(Fb)呈负相关(r=-0.36,P=0.008),与毛细血管通透性表面积乘积(PS)(r=-0.39,P=0.004)和从血液转移到细胞外细胞外空间(EES)(Ktrans)(r=-0.40,P=0.003)呈负相关,与肿瘤体积呈正相关(r=0.34;P=0.004)。高肿瘤微血管增殖、低 Fb 和低 Ktrans 均与降低的无进展/复发生存(P<0.05)显著相关。
伴有微血管增殖和低肿瘤血流的紊乱性血管生成是预后不良的一个危险因素,这表明缺氧与子宫内膜癌的进展和转移扩散有关。